Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.88B |
| 2 |
British American Tobacco
BTI
|
+$746M |
| 3 |
Becton Dickinson
BDX
|
+$691M |
| 4 |
Baker Hughes
BKR
|
+$650M |
| 5 |
CELG
Celgene Corp
CELG
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$2.75B |
| 2 |
Apple
AAPL
|
+$1.81B |
| 3 |
BHI
Baker Hughes
BHI
|
+$1.26B |
| 4 |
Medtronic
MDT
|
+$1.25B |
| 5 |
Charter Communications
CHTR
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.6% |
| 2 | Technology | 16.57% |
| 3 | Healthcare | 14.29% |
| 4 | Communication Services | 11.09% |
| 5 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Voyager Therapeutics
VYGR
$183M
| $76.1M | 0.01% |
3,698,051
-64,000
| -2% | -$722K |
|
1102
Automatic Data Processing
ADP
$106B
| $76M | 0.01% |
695,206
-180,657
| -21% | -$19.3M |
|
|
PRMW
1103
DELISTED
Primo Water Corporation
PRMW
| $75.7M | 0.01% |
5,050,516
-1,031,450
| -17% | -$15.6M |
|
|
FBR
1104
DELISTED
Fibria Celulose Sa
FBR
| $75.6M | 0.01% |
5,580,800
-1,053,000
| -16% | -$12.5M |
|
|
XENT
1105
DELISTED
Intersect ENT, Inc
XENT
| $75.5M | 0.01% |
2,423,626
+940,717
| +63% | +$27.8M |
|
1106
Voya Financial
VOYA
$9.01B
| $75.4M | 0.01% |
1,889,409
-201,650
| -10% | -$7.72M |
|
|
NUAN
1107
DELISTED
Nuance Communications, Inc.
NUAN
| $75.3M | 0.01% |
5,529,903
+337,837
| +7% | +$4.82M |
|
|
ACTA
1108
DELISTED
Actua Corp
ACTA
| $75.1M | 0.01% |
4,908,352
-130,876
| -3% | -$1.72M |
|
1109
Zai Lab
ZLAB
$2.06B
| $74.8M | 0.01% |
+2,768,485
| New | +$77.2M |
|
1110
Pembina Pipeline
PBA
$28.4B
| $74.5M | 0.01% |
2,122,988
-9,393
| -0.4% | -$313K |
|
1111
MarketAxess Holdings
MKTX
$5.71B
| $74.2M | 0.01% |
402,313
-89,400
| -18% | -$17.1M |
|
1112
CBIZ
CBZ
$2.99B
| $74.2M | 0.01% |
4,563,666
-666,151
| -13% | -$10M |
|
1113
Brunswick
BC
$5.13B
| $73.9M | 0.01% |
1,319,565
-1,218,844
| -48% | -$68.4M |
|
|
TCF
1114
DELISTED
TCF Financial Corporation
TCF
| $73.5M | 0.01% |
4,313,406
-10,040,794
| -70% | -$158M |
|
1115
IQVIA
IQV
$38.7B
| $73.4M | 0.01% |
772,283
+103,947
| +16% | +$9.63M |
|
1116
Regenxbio
RGNX
$620M
| $73.4M | 0.01% |
2,227,694
-44,800
| -2% | -$1.01M |
|
|
RESI
1117
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $73.3M | 0.01% |
6,599,916
+210,000
| +3% | +$2.56M |
|
|
HIMX
1118
Himax Technologies
HIMX
$2.19B
| $73.2M | 0.01% |
6,698,136
-2,357,181
| -26% | -$21.4M |
|
|
AIMT
1119
DELISTED
Aimmune Therapeutics
AIMT
| $73.1M | 0.01% |
2,948,885
-67,171
| -2% | -$1.45M |
|
|
FLOW
1120
DELISTED
SPX FLOW, Inc.
FLOW
| $72.9M | 0.01% |
1,891,157
+181,314
| +11% | +$6.41M |
|
|
TFCF
1121
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $72.7M | 0.01% |
2,820,456
+10,866
| +0.4% | +$295K |
|
1122
Johnson Controls International
JCI
$88.8B
| $72.7M | 0.01% |
1,805,139
+1,017,811
| +129% | +$41.2M |
|
1123
Lamar Advertising Co
LAMR
$16.2B
| $72.5M | 0.01% |
1,058,629
+135,213
| +15% | +$9.15M |
|
1124
Ligand Pharmaceuticals
LGND
$5.76B
| $72.4M | 0.01% |
852,932
+209,788
| +33% | +$16.6M |
|
|
CBM
1125
DELISTED
Cambrex Corporation
CBM
| $72.4M | 0.01% |
1,317,044
+246,399
| +23% | +$13.6M |
|
Similar funds
Fidelity Investments's Q3 2017 Portfolio in Review
As of Q3 2017, Fidelity Investments held 2,720 positions worth $827B, up 2.8% from $805B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Fidelity Investments's Q3 2017 filing shows 114 new, 1,012 increased, 1,186 reduced and 130 closed positions. Its largest new stake was Baker Hughes: 18,309,847 shares worth $671M. The largest sale was Du Pont De Nemours E I, an estimated $2.75B.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- Fidelity Investments's largest Q3 2017 buy was Baker Hughes: 18,309,847 shares worth $671M.
- Fidelity Investments added most to DuPont de Nemours in Q3 2017, an estimated $2.88B increase.
- Fidelity Investments's biggest Q3 2017 reduction was Apple, cutting an estimated $1.81B.
- Fidelity Investments fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $2.75B.
- Fidelity Investments's ten largest holdings make up 18% of its $827B portfolio in Q3 2017.
- Fidelity Investments opened 114 new positions and closed 130 in Q3 2017.
- Fidelity Investments's portfolio value rose 2.8% quarter-over-quarter to $827B.
Based on Fidelity Investments's 13F filing for Q3 2017, filed 13 Nov 2017.